Goldman Sachs
NITE

Goldman Sachs’s Nightstar Therapeutics plc American Depositary Shares NITE Stock Holding History

Goldman Sachs’s Portfolio NITE Stock Details NITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-154,754
Closed -$3.93M – 5509
2019
Q1 		$3.93M Buy
+154,754
New +$2.74M ﹤0.01% 3171
2017
Q4 		– Sell
-26,800
Closed -$515K – 6850
2017
Q3 		$515K Buy
+26,800
New +$579K ﹤0.01% 5063

Goldman Sachs's NITE Position: Q2 2019 in Review

Goldman Sachs sold out of Nightstar Therapeutics plc American Depositary Shares (NITE) in Q2 2019, closing a stake of 154,754 shares — an estimated $3.93M sold.

Goldman Sachs first reported a position in NITE in Q3 2017 and held it in 2 quarters. The position peaked at $3.93M in Q1 2019. 0 funds tracked by Wall St. Rank hold NITE as of Q2 2019.

  • Goldman Sachs reported no remaining Nightstar Therapeutics plc American Depositary Shares position as of Q2 2019 after selling out during the quarter.
  • Goldman Sachs sold 154,754 Nightstar Therapeutics plc American Depositary Shares shares in Q2 2019, an estimated $3.93M.
  • Goldman Sachs first reported a position in Nightstar Therapeutics plc American Depositary Shares in Q3 2017 and held it in 2 quarters.
  • Goldman Sachs's Nightstar Therapeutics plc American Depositary Shares position peaked at $3.93M in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Nightstar Therapeutics plc American Depositary Shares as of Q2 2019.

Based on Goldman Sachs's 13F filing for Q2 2019, filed 14 Aug 2019.